137th Canton Fair Casts a Wider Net for Fishing Supplies Manufacturers
GUANGZHOU, China, May 5, 2025 /PRNewswire/ -- In an era where niche hobbies are rapidly entering the mainstream, industries once viewed as traditional are undergoing swift and significant transformation. Fishing, long associated with leisurely...
Ping An Rapidly Launches Overseas Emergency Assistance to Support Chinese Citizens Affected by Major Traffic Accident in the U.S.
HONG KONG and SHANGHAI, May 3, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group", HKEX: 2318; SSE: 601318) has established the "502 Overseas Emergency Assistance Task Force" to coordinate...
137th Canton Fair Sets Off Flavor Frenzy with Playful Snacks & Sweets
GUANGZHOU, China, May 3, 2025 /PRNewswire/ -- From May 1 to 5, under the theme "Better Life," Phase 3 of the 137th China Import and Export Fair (Canton Fair) offered more than just trade. It provided a multi-sensory journey into the heart of China's...
The 137th Canton Fair Sees a Booming Market for All-Age Toys
GUANGZHOU, China, May 2, 2025 /PRNewswire/ -- Phase 3 of the 137th China Import and Export Fair (Canton Fair), held from May 1 to 5, features 11,759 export exhibitors under the theme "Better Life." The event sees the shifting dynamics of the global...
A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis
SUZHOU, China, May 1, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III clinical trial of anti-HER2 bispecific antibody KN026...
Rediscovering Quality Home Life Through Nature-Inspired Design at 137th Canton Fair
GUANGZHOU, China, May 1, 2025 /PRNewswire/ -- In the fast-paced rhythm of modern urban life, a home has evolved beyond being merely a place to rest, it has become a sanctuary for emotional recharge. While smart technologies continue to redefine...
S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial
SEOUL, South Korea, May 1, 2025 /PRNewswire/ -- S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate a Phase 1b...
Mingteng International Corporation Inc. Announces Financial Results for Fiscal Year 2024
WUXI, China, April 30, 2025 /PRNewswire/ -- Mingteng International Corporation Inc. (Nasdaq: MTEN) (the "Company" or "Mingteng International"), an automotive mold developer and supplier in China, today announced its financial results for the fiscal...
Epicsoft Asia Pte. Ltd. Announces Voluntary Conditional Cash Offer for Ban Leong Technologies Limited at S$0.6029 per Share
Transaction expected to expand the GCL group's bundled product offerings and have a positive impact on GCL's adjusted EBITDA SINGAPORE, April 30, 2025 /PRNewswire/ -- Epicsoft Asia Pte. Ltd. ("Offeror" or the "Company"), an indirect wholly-owned...
JediCare Medical has announced successful completion of its first-in-human feasibility study of the world's first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection
SHANGHAI, April 30, 2025 /PRNewswire/ -- JediCare Medical Technology Co., Ltd. a Shanghai, China based company ("the Company"), jointly with West China Hospital of Sichuan University, recently announced the successful completion of first-in-human...